Injectable host-guest gel nanovaccine for cancer immunotherapy against melanoma

Injectable host-guest gel nanovaccine for cancer immunotherapy against melanoma

Despite the extensive development of peptide-based tumor antigen vaccines, the field still faces up enormous challenges from lacking clinical efficacy. Here, we report the design and development of a therapeutic nanovaccine for cancer immunotherapy by using gold nanoparticle (AuNPs)-conjugated pepti...

Full description

Bibliographic Details
Main Authors: Kaige Xu, Yuxiang Wen, Xingying Zhang, Yuqing Liu, Ding Qiu, Baohua Li, Lixin Zheng, Yuzhang Wu, Malcolm Xing, Jian Li
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Materials Today Advances
Subjects:
Cancer immunotherapy
Antigen peptides
Nanovaccine
Antigen cross-presentation
Host-guest hydrogel
Online Access:http://www.sciencedirect.com/science/article/pii/S2590049822000327

Internet

http://www.sciencedirect.com/science/article/pii/S2590049822000327

Similar Items